Please login to the form below

Not currently logged in
Email:
Password:

F-star Alpha

This page shows the latest F-star Alpha news and features for those working in and with pharma, biotech and healthcare.

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug

BMS taps F-star Alpha for immuno-oncology drug. Drug in development for breast and stomach cancers. ... Bristol-Myers Squibb (BMS) has hatched a plan to buy Austrian biotech F-star Alpha in order to claim rights to FS102, a drug in development for

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    525. F-star Alpha/BMS. Option to acquire F-star Alpha. Includes FS102 a P1 ready treatment for HER2 positive patients with breast / gastric cancer.

  • Pharma deals during October 2014 Pharma deals during October 2014

    This month is no exception with Bristol-Myers Squibb (BMS) securing an exclusive option to acquire F-star Alpha gaining access to its lead candidate FS102 for HER-2 positive patients

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics